Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
Incyte Corporation
Incyte Corporation
Shenzhen TargetRx, Inc.
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Ascentage Pharma Group Inc.
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Incyte Corporation
Takeda
Nohla Therapeutics, Inc.
Merck Sharp & Dohme LLC
Teva Branded Pharmaceutical Products R&D, Inc.
Mesoblast, Ltd.
Bristol-Myers Squibb
Cellerant Therapeutics
INSYS Therapeutics Inc
Novartis
Bristol-Myers Squibb